Focus: Avantor is a $7.0B revenue global life sciences company providing critical materials, equipment, and services to the pharmaceutical, biotech, and research sectors. Operating at massive scale with 10,000+ employees, it serves as essential infrastructure for drug development and manufacturing worldwide.
Profile data last refreshed 22h ago · AI intelligence enriched 1mo ago
Hot — 352 jobs added in 30d
Net +151 (352 new, 201 removed). Aggressive expansion phase.
Strong fit for supply chain, manufacturing, and R&D operations roles in a stable, large-scale infrastructure business; limited appeal for those seeking direct drug discovery and development experience.
Help build intelligence for Avantor
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Avantor's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles